Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04675255 · ClinicalTrials.gov registry record · NA
Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04675255: Completed NA study, sponsored by Washington University School of Medicine.
NCT04675255 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04675255, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
A substudy of TMC114FD2HTX4004 that will perform glucose tolerance testing, adipose testing and MRI scan at baseline, 12 and 24 weeks post switch of ART medications.
Primary Outcome
Change in insulin sensitivity (SI) at 12 weeks assessed by using a 3-hour frequently sampled oral glucose tolerance testing (fsOGTT).to calculate HOMA\_IR
Interventions
- PROCEDURE Frequently sampled glucose tolerance testing
- PROCEDURE abdominal subcutaneous adipose tissue biopsy
- PROCEDURE MRI scan to assess intrahepatic triglyceride content
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2023-06-08 |
| Phase | NA |
What the finished NCT04675255 record still lists
NCT04675255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Frequently sampled glucose tolerance testing is the first listed.
NCT04675255 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04675255 about?
NCT04675255 is a clinical study titled "Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism". A substudy of TMC114FD2HTX4004 that will perform glucose tolerance testing, adipose testing and MRI scan at baseline, 12 and 24 weeks post switch of ART medications.
What is the current status of trial NCT04675255?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2021-01-01. Estimated completion is 2023-06-08.
What interventions are being tested in trial NCT04675255?
The interventions under investigation include: Frequently sampled glucose tolerance testing (PROCEDURE), abdominal subcutaneous adipose tissue biopsy (PROCEDURE), MRI scan to assess intrahepatic triglyceride content (PROCEDURE).
Who is sponsoring clinical trial NCT04675255?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04675255's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI